COMPOSES INHIBITEURS DE MTOR

Patent europeic · EP3727390 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3727390
Numer da la dumonda
EP18826025
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-12-2018
Publitgà
28-10-2020
Concedì
22-03-2023
Stritgà
23-07-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 487/04 (2006.01)
C07D 487/20 (2006.01)
A61K 31/519 (2006.01)
A61P 17/00 (2006.01)
Prioritad
FR 1771402 21.12.2017
Dumonda PCT
PCT/EP2018/086074 20.12.2018
Publicaziun PCT
WO2019/122065 27.06.2019
Lingua da l’annunzia
franzos
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.07.2024

  2. 31-01-2024

    Midada

    Published in Swissreg on 31.01.2024

  3. 22-03-2023

    Concedì

    Published in Swissreg on 22.03.2023

Partidas

Possessur

GALDERMA RESEARCH & DEVELOPMENT

Galderma Research & Development

2400 Route des Colles Les Templiers, 06410 Biot, FR

Inventur

OUVRY, Gilles

Abingdon, OXI143TA Oxfordshire, FR

THOREAU, Etienne

06460 Saint Vallier De Thiey, FR

TOMAS, Loïc

1814 La-Tour-de-Peilz

BHURRUTH-ALCOR, Yushma

Ashburn, Virginie 20147, US

FOURNIER, Jean-François

06600 Antibes, FR

CLARY, Laurence

06480 La Colle Sur Loup, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.